Catalyst Pharmaceutical Inc. (CPRX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CPRX. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 19,158,785 | $602M | INCREASED |
| Vanguard | 8,562,480 | $269M | DECREASED |
| State Street | 7,627,036 | $240M | INCREASED |
| American Century Companies | 5,553,921 | $175M | INCREASED |
| Dimensional Fund Advisors | 3,634,171 | $114M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Michael Wayne Kalb (Chief Financial Officer) | SELL | 39,701 | 2026-07-15 | |
| Michael Wayne Kalb (Chief Financial Officer) | SELL | 13,788 | 2026-07-15 | |
| Michael Wayne Kalb (Chief Financial Officer) | SELL | 21,416 | 2026-07-15 | |
| Michael Wayne Kalb (Chief Financial Officer) | SELL | 131,536 | $3M | 2026-07-15 |
| Michael Wayne Kalb (Chief Financial Officer) | SELL | 169,248 | $4M | 2026-07-15 |
Full institutional holdings, insider history, and congressional trades for Catalyst Pharmaceutical Inc. on SentiSense.